Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

8,437 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,769
Recruiting: 1,010
Ph III recruiting: 99
Growth YoY: −1.7%
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 35.6%
Trials / 1,000 deaths: 75 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,348)

clinicaltrialsPublishedShowing 151–200 of 863 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07163793	Pilot Study of Reduced Venetoclax Exposure	active not recruiting	Phase 2	41	Northwell HealthOTHER	1	Aug 27, 2026	clinicaltrials
NCT07789574	Efficacy of Asciminib in Chronic Phase CML Patients With T315I Mutations(ESTIMATION)	active not recruiting	Phase 2	50	Thomas Ernst, PD Dr. med.OTHER	1	Aug 27, 2026	clinicaltrials